Carcinoma, Ehrlich Tumor - Drug therapy
Research News and Information

Monday, November 23, 2009

Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.

30 Aug 2009 The inhibitory effect of phenothiazines in tumor growth and cancer cell proliferation in vitro and in vivo has been established. These reports motivated us to investigate the genotoxic, cytotoxic, and cytostatic potential of chlorpromazine, alone or ... Read more...

Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.

27 May 2009 The synthesis, in vivo and in vitro antitumor evaluation, and QSAR studies of some novel pyrazole analogs against Ehrlich Ascites Carcinoma (EAC) cells were described. In vitro results revealed that compounds 10, 6 and 4 were the most potent analogs ... Read more...

Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo.

18 May 2009 In this study, DNA damage in tumour cells, as well as irreversible cell damage leading to apoptosis induced in vivo by the combined application of cisplatin and inhalation anaesthetics, was investigated. The genotoxicity of anaesthetics on Ehrlich ... Read more...

Latest indexed articles for 'Carcinoma, Ehrlich Tumor - Drug therapy'

These are the very latest articles for this heading:

• Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo. 30 Aug 2009
• Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs. 27 May 2009
• Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo. 18 May 2009
• Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma. 21 Apr 2009
• Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents. 15 Apr 2009
• Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells. 14 Apr 2009
• Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo. 27 Feb 2009
• Polysaccharide fraction of Agaricus brasiliensis avoids tumor-induced IL-10 production and changes the microenvironment of subcutaneous Ehrlich adenocarcinoma. 22 Feb 2009
• Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate. 15 Feb 2009
• Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae). 13 Feb 2009
• Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties. 30 Dec 2008
• Long-term caffeine consumption reverses tumor-induced suppression of the innate immune response in adult mice. 16 Nov 2008
• Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models. 10 Nov 2008
• Preliminary investigation of the radiosensitizing activity of guduchi (Tinospora cordifolia) in tumor-bearing mice. 30 Oct 2008
• Antimicrobial and antineoplasic activity of Pleurotus ostreatus. 30 Sep 2008
• Antitumoral and antiangiogenic activity of Synadenium umbellatum Pax. 31 Aug 2008
• Safety, pharmacokinetics and biodistribution studies of a beta-galactoside prodrug of doxorubicin for improvement of tumor selective chemotherapy. 30 Jul 2008
• Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo. 30 Jul 2008
• Active oxygen intermediates in the degradation of hematoporphyrin derivative in tumor cells subjected to photodynamic therapy. 22 Jul 2008
• Antineoplasic activity of Copaifera multijuga oil and fractions against ascitic and solid Ehrlich tumor. 3 Jul 2008

See a longer list of these articles.

Technical information about 'Carcinoma, Ehrlich Tumor'

Definition: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Descriptor UI: D002286

Alternative terms: Carcinoma, Ehrlich Tumor; Ehrlich Tumor Carcinoma; Ehrlich Ascites Tumor; Ascites Tumor, Ehrlich; Tumor, Ehrlich Ascites;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; secondary; secretion; surgery; therapy; ultrastructure; urine; ultrasonography; chemistry; virology;

Tree Number: C04.557.470.200.200; C04.619.169;

Technical Notes: exper neopl; /blood supply /chem /second /secret /ultrastruct permitted; note X ref: do not also index under ASCITES; don't forget check tag ANIMALS